Gateway for Cancer Research

Friday, April 17, 2020
Scottsdale Hangar One

If we want to change tomorrow, we have to act today!

Join Gateway for Cancer Research for the 4th Annual Vino con Stelle

April 23, 2021 | Scottsdale Hangar One

Cancer won’t wait. Over 4,930 people are diagnosed with cancer in the United States every day. By funding lifesaving clinical trials we continue to make an impact, not only on the future of cancer, but for patients living with the disease today

Join us for an evening you won’t soon forget and a chance to be a part of lifesaving cancer research that brings hope to people living with this pervasive disease that they truly can feel better, live longer and conquer cancer!

Vino con Stelle, the signature fundraising event for Gateway for Cancer Research held annually in Scottsdale, Arizona, raises funds to support breakthrough cancer clinical trials and will be Co-Chaired by the Vice Chairman of Gateway and Gateway’s Co-Founder and Chairman, Dr. Stacie J. and Mr. Richard J Stephenson. Thanks to generous underwriting, 99 cents of every dollar donated goes directly toward cancer research globally.

This unforgettable evening of wine under the stars is a celebration of what has been 29 years spent demanding cures and fighting to end cancer through Gateway for Cancer Research.

Guests will delight in an evening of exquisite culinary creations, thoughtfully curated wines, world class entertainment, once-in-a-lifetime live auction bidding opportunities and, of course, dancing.

Since its inception in 1991, Gateway has provided over $85 million in funding for more than 170 Phase I and Phase II clinical trials benefiting over 5,500 cancer patients at leading institutions worldwide. Early phase trials have been shown to have the greatest impact in curing cancer yet are significantly under funded making Gateway for Cancer Research that much more impactful in the fight against cancer.

Chairman Richard J Stephenson and Vice Chairman Dr. Stacie J. Stephenson

2020 Major Sponsors:

99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions